Hill-Rom Holdings (NYSE: HRC) is one of 80 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its competitors? We will compare Hill-Rom Holdings to similar businesses based on the strength of its earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Insider and Institutional Ownership

82.1% of Hill-Rom Holdings shares are owned by institutional investors. Comparatively, 67.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 2.2% of Hill-Rom Holdings shares are owned by insiders. Comparatively, 11.7% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dividends

Hill-Rom Holdings pays an annual dividend of $0.72 per share and has a dividend yield of 0.9%. Hill-Rom Holdings pays out 36.2% of its earnings in the form of a dividend. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 36.9% of their earnings in the form of a dividend. Hill-Rom Holdings has increased its dividend for 6 consecutive years. Hill-Rom Holdings is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Hill-Rom Holdings and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hill-Rom Holdings 0 1 5 0 2.83
Hill-Rom Holdings Competitors 205 1198 2673 86 2.63

Hill-Rom Holdings currently has a consensus target price of $88.33, indicating a potential upside of 14.82%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 7.08%. Given Hill-Rom Holdings’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Hill-Rom Holdings is more favorable than its competitors.

Earnings and Valuation

This table compares Hill-Rom Holdings and its competitors gross revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Hill-Rom Holdings $2.74 billion $133.60 million 38.66
Hill-Rom Holdings Competitors $1.03 billion $127.56 million 215.30

Hill-Rom Holdings has higher revenue and earnings than its competitors. Hill-Rom Holdings is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Hill-Rom Holdings and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hill-Rom Holdings 4.87% 20.27% 5.87%
Hill-Rom Holdings Competitors -125.29% -43.73% -11.32%

Volatility and Risk

Hill-Rom Holdings has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Hill-Rom Holdings’ competitors have a beta of 1.10, suggesting that their average share price is 10% more volatile than the S&P 500.

Summary

Hill-Rom Holdings beats its competitors on 12 of the 15 factors compared.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc. is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions. The Company sells and rents its specialty frames and surfaces, and mobility solutions, as well as its clinical workflow solutions, in the United States and Canada through its North America Patient Support Systems segment, and in regions outside of the United States and Canada through its International Patient Support Systems segment. Its Front Line Care segment globally sells and rents respiratory care products, and sells medical diagnostic equipment and a diversified portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases. Under its Surgical Solutions segment, the Company sells its surgical products globally.

Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.